載入...
Co-inhibition of EGFR and IGF1R synergistically impacts therapeutically on adrenocortical carcinoma
PURPOSE: Adrenocortical carcinoma (ACC) is a rare tumor with very poor prognosis and no effective treatment. The aim of this study was to explore a novel therapy co-targeting EGFR and IGF1R in vitro and vivo. METHODS: The expression of EGFR and IGF1R were evaluated in a series of adrenocortical tumo...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5094996/ https://ncbi.nlm.nih.gov/pubmed/27105537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8827 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|